Showing results (71-80 of 119) with videos related to
Sort By:
Pageof 12
Molecular Oncology|September 20, 2012
Multifunctional protein APPL2 contributes to survival of human glioma cellsBeata Pyrzynska, Magdalena Banach-Orlowska, Marta Teperek-Tkacz, et al.International Journal of Molecular Sciences|January 10, 2026
Cytoprotective and Immunomodulatory Properties of Mesenchymal Stem Cell Secretome and Its Effect on Organotypic Hippocampal Cultures in Mouse Model of Temporal Lobe EpilepsyMartyna Strzelec, Jan Detka, Marta Kot, et al.Reproductive Biology and Endocrinology : RB&E|October 7, 2010
The frequency of CD25+CD4+ and FOXP3+ regulatory T cells in ectopic endometrium and ectopic deciduaPawel Basta, Marcin Majka, Wojciech Jozwicki, et al.Cell Transplantation|August 30, 2023
Comparative Analysis of the Results of Stroke Treatment With Multiple Administrations of Wharton's Jelly Mesenchymal Stem Cells-Derived HE-ATMP and Standard Conservative Treatment: Case Series StudyOlga Milczarek, Jakub Swadźba, Patrycja Swadźba, et al.Molecules (Basel, Switzerland)|September 23, 2020
The Potential of Novel Chitosan-Based Scaffolds in Pelvic Organ Prolapse (POP) Treatment through Tissue EngineeringJulia Radwan-Pragłowska, Klaudia Stangel-Wójcikiewicz, Marek Piątkowski, et al.Cancer Research|July 19, 2017
MCPIP1 Downregulation in Clear Cell Renal Cell Carcinoma Promotes Vascularization and Metastatic ProgressionPaulina Marona, Judyta Górka, Zofia Mazurek, et al.Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|March 10, 2018
Blocking MET receptor signaling in multiple myeloma cells in vitro and in vivoArtur Jurczyszyn, Anna Zebzda, Joanna Gdula-Argasińska, et al.Experimental Hematology|July 24, 2002
Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and plateletsMarcin Majka, Janina Ratajczak, Gaston Villaire, et al.International Journal of Molecular Sciences|March 6, 2021
Selective Cytotoxicity of Complexes with N,N,N-Donor Dipodal Ligand in Tumor CellsMalgorzata Tyszka-Czochara, Anna Adach, Tomasz Grabowski, et al.Journal of Cancer|June 25, 2014
Geldanamycin and Its Derivatives Inhibit the Growth of Myeloma Cells and Reduce the Expression of the MET ReceptorArtur Jurczyszyn, Anna Zebzda, Jacek Czepiel, et al.Pageof 12